GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovis Corp (STU:C520) » Definitions » Institutional Ownership

Enovis (STU:C520) Institutional Ownership : 85.97% (As of May. 24, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Enovis Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Enovis's institutional ownership is 85.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Enovis's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Enovis's Float Percentage Of Total Shares Outstanding is 87.15%.


Enovis Institutional Ownership Historical Data

The historical data trend for Enovis's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovis Institutional Ownership Chart

Enovis Historical Data

The historical data trend for Enovis can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 83.16 84.41 86.65 84.66 84.50 86.70 86.95 87.23 86.10 85.97

Enovis Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Enovis (STU:C520) Business Description

Traded in Other Exchanges
Address
2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy.. The company conducts its operations through two operating segments: Prevention & Recovery ("P&R") and Reconstructive ("Recon"). It generates majority revenue form Prevention & Recovery segment.

Enovis (STU:C520) Headlines

No Headlines